Clinical Trial Update: Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results assess the safety and efficacy of arformoterol tartrate inhalation solution in chronic obstructive pulmonary disease, with the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Brovana (arformoterol tartrate) inhalation solution (arformoterol tartrate)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Chronic Obstructive Pulmonary Disease, Bronchitis | Phase 3 | Status: COMPLETED | Results posted: 2009-02-19